Search Results

There are 43347 results for: content related to: Salvage radiation in men after prostate-specific antigen failure and the risk of death

  1. You have free access to this content
    Prostate-specific antigen doubling time among Japanese men in an annual health screening program

    International Journal of Urology

    Volume 11, Issue 10, October 2004, Pages: 856–861, AKITO TERAI, YOSHIYUKI MATSUI, KENTARO ICHIOKA, HIROKI OHARA, NAOKI TERADA and KOJI YOSHIMURA

    Version of Record online : 12 OCT 2004, DOI: 10.1111/j.1442-2042.2004.00904.x

  2. You have free access to this content
    Global update on defining and treating high-risk localized prostate cancer with leuprorelin: a USA perspective – identifying men at diagnosis who are at high risk of prostate cancer death after surgery or radiation therapy

    BJU International

    Volume 99, Issue s1, January 2007, Pages: 13–16, Anthony D’Amico

    Version of Record online : 8 DEC 2006, DOI: 10.1111/j.1464-410X.2007.06594.x

  3. You have free access to this content
    Predictors of mortality after androgen-deprivation therapy in patients with rapidly rising prostate-specific antigen levels after local therapy for prostate cancer

    Cancer

    Volume 107, Issue 3, 1 August 2006, Pages: 514–520, Neesha A. Rodrigues, Ming-Hui Chen, William J. Catalona, Kimberly A. Roehl, Jerome P. Richie and Anthony V. D'Amico

    Version of Record online : 22 JUN 2006, DOI: 10.1002/cncr.22018

  4. You have free access to this content
    Deferred combined androgen blockade therapy using bicalutamide in patients with hormone-refractory prostate cancer during androgen deprivation monotherapy

    BJU International

    Volume 97, Issue 6, June 2006, Pages: 1184–1189, YASUHISA FUJII, SATORU KAWAKAMI, HITOSHI MASUDA, TSUYOSHI KOBAYASHI, NOBUHIKO HYOCHI, YUKIO KAGEYAMA and KAZUNORI KIHARA

    Version of Record online : 9 MAY 2006, DOI: 10.1111/j.1464-410X.2006.06149.x

  5. A pilot study of the utility of choline PET–CT in prostate cancer biochemical relapse following radical prostatectomy

    Journal of Medical Imaging and Radiation Oncology

    Volume 60, Issue 3, June 2016, Pages: 374–381, Hendrick Tan, David Joseph, Nelson K Loh, Michael McCarthy, Eugene Leong, Teck Siew, Tatiana Segard, Laurence Morandeau, Michelle Trevenen and Roslyn J Francis

    Version of Record online : 20 APR 2016, DOI: 10.1111/1754-9485.12455

  6. The relationship between prostate-specific antigen and TNM classification or Gleason score in prostate cancer patients with low prostate-specific antigen levels

    The Prostate

    Volume 75, Issue 10, July 1, 2015, Pages: 1034–1042, Kouji Izumi, Hiroko Ikeda, Aerken Maolake, Kazuaki Machioka, Takahiro Nohara, Kazutaka Narimoto, Satoru Ueno, Yoshifumi Kadono, Yasuhide Kitagawa, Hiroyuki Konaka, Atsushi Mizokami and Mikio Namiki

    Version of Record online : 8 MAR 2015, DOI: 10.1002/pros.22985

  7. You have free access to this content
    Active surveillance; a reasonable management alternative for patients with prostate cancer: the Miami experience

    BJU International

    Volume 101, Issue 2, January 2008, Pages: 165–169, Mark S. Soloway, Cynthia T. Soloway, Steve Williams, Rajinikanth Ayyathurai, Bruce Kava and Murugesan Manoharan

    Version of Record online : 10 SEP 2007, DOI: 10.1111/j.1464-410X.2007.07190.x

  8. You have free access to this content
    Definition and preoperative predictors of persistently elevated prostate-specific antigen after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database

    BJU International

    Volume 105, Issue 11, June 2010, Pages: 1541–1547, Daniel M. Moreira, Joseph C. Presti Jr, William J. Aronson, Martha K. Terris, Christopher J. Kane, Christopher L. Amling and Stephen J. Freedland

    Version of Record online : 12 NOV 2009, DOI: 10.1111/j.1464-410X.2009.09016.x

  9. You have free access to this content
    Phytotherapeutic interventions in the management of biochemically recurrent prostate cancer: a systematic review of randomised trials

    BJU International

    Volume 117, Issue S4, April 2016, Pages: 17–34, Margaret Diana van Die, Kerry M. Bone, Jon Emery, Scott G. Williams, Marie V. Pirotta and Channing J. Paller

    Version of Record online : 22 FEB 2016, DOI: 10.1111/bju.13361

  10. You have free access to this content
    Prostate carcinoma screening in the county of Tyrol, Austria

    Cancer

    Volume 80, Issue 9, 1 November 1997, Pages: 1818–1829, Andreas Reissigl, W. Horninger, K. Fink, H. Klocker and G. Bartsch

    Version of Record online : 20 NOV 2000, DOI: 10.1002/(SICI)1097-0142(19971101)80:9<1818::AID-CNCR21>3.0.CO;2-7

  11. You have free access to this content
    Prostate-specific antigen velocity based risk-adapted discontinuation of prostate cancer screening in elderly men

    BJU International

    Volume 108, Issue 1, July 2011, Pages: 44–48, Ping Tang, Leon Sun, Matthew A. Uhlman, Cary N. Robertson, Thomas J. Polascik and Judd W. Moul

    Version of Record online : 2 NOV 2010, DOI: 10.1111/j.1464-410X.2010.09812.x

  12. You have free access to this content
    Annual PSA tests are not necessary for men with a PSA level below 2 ng/mL: Findings of the Imari prostate cancer screening program

    International Journal of Urology

    Volume 9, Issue 6, June 2002, Pages: 334–339, Jiro Uozumi, Yuji Tokuda, Chisato Fujiyama, Norito Takagi, Hiroyuki Meiri, Kazunari Kuratomi, Kouji Nakamura, Yasuhisa Ichigi, Hidetoshi Yoshinaga, Norio Kinoshita and Zenjiro Masaki

    Version of Record online : 23 JUL 2002, DOI: 10.1046/j.1442-2042.2002.00474.x

  13. You have free access to this content
    Cost-effectiveness of Prostate Health Index for prostate cancer detection

    BJU International

    Volume 110, Issue 3, August 2012, Pages: 353–362, Michael B. Nichol, Joanne Wu, Joice Huang, Dwight Denham, Stanley K. Frencher and Steven J. Jacobsen

    Version of Record online : 11 NOV 2011, DOI: 10.1111/j.1464-410X.2011.10751.x

  14. You have free access to this content
    Prostate specific antigen velocity as a measure of the natural history of prostate cancer: defining a ‘rapid riser’ subset

    British Journal of Urology

    Volume 81, Issue 1, January 1998, Pages: 100–104, Nam, Klotz, Jewett, Danjoux and Trachtenberg

    Version of Record online : 25 DEC 2001, DOI: 10.1046/j.1464-410x.1998.00523.x

  15. You have free access to this content
    Significance of prostate-specific antigen-doubling time on survival of patients with hormone refractory prostate cancer and bone metastasis: Analysis on 56 cases of cancer-specific death

    International Journal of Urology

    Volume 14, Issue 2, February 2007, Pages: 123–127, Susumu Tomioka, Masaki Shimbo, Yoshiyasu Amiya, Hiroomi Nakatsu, Shino Murakami and Jun Shimazaki

    Version of Record online : 19 JAN 2007, DOI: 10.1111/j.1442-2042.2007.01672.x

  16. You have free access to this content
    Gleason score 7 screen-detected prostate cancers initially managed expectantly: outcomes in 50 men

    BJU International

    Volume 103, Issue 11, June 2009, Pages: 1472–1477, Roderick C.N. Van Den Bergh, Stijn Roemeling, Monique J. Roobol, Gunnar Aus, Jonas Hugosson, Antti S. Rannikko, Teuvo L. Tammela, Chris H. Bangma and Fritz H. Schröder

    Version of Record online : 19 JAN 2009, DOI: 10.1111/j.1464-410X.2008.08281.x

  17. You have free access to this content
    Clinical trials in patients with biochemically relapsed prostate cancer

    BJU International

    Volume 97, Issue 5, May 2006, Pages: 905–910, AMY M. LIN, BRIAN I. RINI and ERIC J. SMALL

    Version of Record online : 6 APR 2006, DOI: 10.1111/j.1464-410X.2006.06124.x

  18. You have free access to this content
    Progression after docetaxel-based chemotherapy in androgen-independent prostate cancer

    BJU International

    Volume 100, Issue 3, September 2007, Pages: 533–535, Avishay Sella, Cora Sternberg, Svetlana Kovel, Nirit Yarom and Iwona Skoneczna

    Version of Record online : 8 JUN 2007, DOI: 10.1111/j.1464-410X.2007.07037.x

  19. You have free access to this content
    Undetectable prostate specific antigen at 6–12 months

    Cancer

    Volume 103, Issue 12, 15 June 2005, Pages: 2499–2506, Nicole Miller, Mark E. Smolkin, Eric Bissonette and Dan Theodorescu

    Version of Record online : 25 APR 2005, DOI: 10.1002/cncr.21077

  20. Anti-angiogenic activity of PSA-derived peptides

    The Prostate

    Volume 75, Issue 12, September 1, 2015, Pages: 1285–1299, Kailash C. Chadha, Bindukumar Nair, Alejandro Godoy, Rajendram Rajnarayanan, Erik Nabi, Rita Zhou, Neel R. Patel, Ravikumar Aalinkeel, Stanley A. Schwartz and Gary J. Smith

    Version of Record online : 11 MAY 2015, DOI: 10.1002/pros.23010